Pregnant women injected with low molecular weight heparin calcium should pay attention to regularly checking coagulation function and liver function. If the examination is normal, it can be stopped 24 hours before delivery, which can reduce the occurrence of bleeding. In the late stage of pregnancy, the blood of pregnant women will be in a hypercoagulable state, mainly to prevent hemorrhage during childbirth.
1. When pregnant women have a low tendency to bleed, they can inject low molecular weight heparin calcium to improve their physical condition, but there is still a risk of bleeding after medication. In addition, low molecular weight heparin calcium is also prone to allergic reactions such as skin itching, rash, urticaria, etc.
2. Low molecular weight heparin cannot be used in patients with thrombocytopenia because thrombocytopenia may cause positive coagulation reactions in the patient's body, and the patient cannot use it.
3. Patients with a history of allergies, bleeding tendencies, or coagulation disorders, such as patients with gastric and duodenal ulcers, stroke, severe liver disease, hepatitis, renal disease, hypertension, hyperglycemia, retinal vascular disease, etc., cannot use it. Pregnant women may also experience symptoms of threatened abortion. Low molecular weight heparin calcium cannot be used as an anticoagulant in extracorporeal circulation, which is not good for the human body.
4. Low molecular weight heparin calcium is not suitable for use in pregnant women during the first 3 months of pregnancy or postpartum women, as the drug may increase the risk of bleeding in pregnant women. Therefore, patients without special needs must use this drug with caution.
